| Literature DB >> 17444820 |
Andrew C Steer1, Margaret H Danchin, Jonathan R Carapetis.
Abstract
The group A streptococcus causes the widest range of disease in humans of all bacterial pathogens. Group A streptococcal diseases are more common in children than adults with diseases ranging from pharyngitis and impetigo to invasive infections and the post-streptococcal sequelae--acute rheumatic fever and acute post-streptococcal glomerulonephritis. The global burden of severe group A streptococcal disease is concentrated largely in developing countries and Indigenous populations such as Aboriginal Australians. Control of group A streptococcal disease is poor in these settings and the need for a vaccine has been argued. With an ever-increasing understanding of the group A streptococcus at a molecular level, new and sophisticated vaccines are currently in human trials and the next decade holds exciting prospects for curbing group A streptococcal diseases.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17444820 DOI: 10.1111/j.1440-1754.2007.01051.x
Source DB: PubMed Journal: J Paediatr Child Health ISSN: 1034-4810 Impact factor: 1.954